Current analysis has revealed that in multiple myeloma cells, berberine can promote the expression of programmed cell death 4(PDCD4) via the restoration of miR-21, an oncomir that involves in tumor protein p53 (TP53) signaling and other cancer pathways [18]. Here, PDCD4 is linked to plasma cell myeloma.